Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cullinan Therapeutics (CGEM) Other Accumulated Expenses (2021 - 2022)

Cullinan Therapeutics (CGEM) has 2 years of Other Accumulated Expenses data on record, last reported at $2.0 million in Q4 2022.

  • For Q4 2022, Other Accumulated Expenses rose 100.92% year-over-year to $2.0 million; the TTM value through Dec 2022 reached $2.0 million, up 100.92%, while the annual FY2022 figure was $2.0 million, 100.92% up from the prior year.
  • Other Accumulated Expenses reached $2.0 million in Q4 2022 per CGEM's latest filing, up from $973000.0 in the prior quarter.
  • Across five years, Other Accumulated Expenses topped out at $2.0 million in Q4 2022 and bottomed at $973000.0 in Q4 2021.